Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultralife (ULBI) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Ultralife (ULBI) over the last 15 years, with Q3 2025 value amounting to $84.8 million.

  • Ultralife's Total Liabilities rose 12430.77% to $84.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $84.8 million, marking a year-over-year increase of 12430.77%. This contributed to the annual value of $86.3 million for FY2024, which is 6322.73% up from last year.
  • As of Q3 2025, Ultralife's Total Liabilities stood at $84.8 million, which was up 12430.77% from $82.3 million recorded in Q2 2025.
  • In the past 5 years, Ultralife's Total Liabilities ranged from a high of $87.1 million in Q1 2025 and a low of $17.3 million during Q2 2021
  • Moreover, its 4-year median value for Total Liabilities was $53.6 million (2023), whereas its average is $52.7 million.
  • Its Total Liabilities has fluctuated over the past 5 years, first tumbled by 4835.99% in 2021, then soared by 12569.64% in 2025.
  • Over the past 4 years, Ultralife's Total Liabilities (Quarter) stood at $18.3 million in 2021, then soared by 189.33% to $52.8 million in 2023, then surged by 63.23% to $86.3 million in 2024, then dropped by 1.68% to $84.8 million in 2025.
  • Its Total Liabilities was $84.8 million in Q3 2025, compared to $82.3 million in Q2 2025 and $87.1 million in Q1 2025.